Time-course based assessment of patient factors and their relationship to chemotherapy induced peripheral neuropathy
These findings indicate that those experiencing CIPN were more likely to report reduced physical functioning, increased anxiety and depression, and have higher BMIs. As new multi-modal approaches are developed for CIPN, pre-treatment physical functioning, BMI and other patient reported measures may provide predictive ability.
Authors
- Courtney E. Hershberger (ORCID: https://orcid.org/0000-0002-2195-989X)
- Anukriti Sharma
- Alper Sen
- Joseph Foss (ORCID: https://orcid.org/0000-0002-4050-7151)
- K. A. Johnson
- Emily E. Rhoades
- Jacob Steenblik
- Daniel Miller Rotroff (ORCID: https://orcid.org/0000-0003-0553-3220)
- Mei Wei
- Carla Bou Dargham
- G. Thomas Budd
- N. Lynn Henry
- Bihua Bie
Institutions
- Cleveland Clinic (US)
- University of Utah (US)
- University of Michigan (US)
- Huntsman Cancer Institute (US)
- Cancer Institute (WIA) (IN)
- Cleveland Clinic Lerner College of Medicine (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- Frontiers in Pain Research
- Published
- 2026-01-30
- DOI
- https://doi.org/10.3389/fpain.2026.1619858
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health